Yantai, China

Qinbin Zhang

This inventor holds 1 USPTO granted patent. Top assignee: Remegen, Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qinbin Zhang. Retrieved from https://idiyas.com/inventor/qinbin-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Qinbin Zhang

Introduction

Qinbin Zhang is a prominent inventor based in Yantai, China. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies. His work has the potential to impact various medical applications.

Latest Patents

Qinbin Zhang holds a patent for an "ANTI-CLAUDIN 18.2 ANTIBODY AND ANTIBODY-DRUG CONJUGATE THEREOF." This patent represents a significant advancement in targeted therapies, showcasing his expertise in antibody development. He has 1 patent to his name, reflecting his commitment to innovation in the medical field.

Career Highlights

Zhang is currently employed at Remegen Ltd., a company known for its focus on biopharmaceuticals. His role at Remegen allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Throughout his career, Qinbin Zhang has worked alongside notable colleagues such as Jianmin Fang and Jing Jiang. These collaborations have fostered a productive environment for innovation and have led to advancements in their respective fields.

Conclusion

Qinbin Zhang's contributions to biotechnology and his innovative patent demonstrate his dedication to advancing medical science. His work at Remegen Ltd. and collaborations with esteemed colleagues further highlight his impact in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…